Document ID: chunk:federal_register_of_legislation:F2016L01332:reg:194:p2
Version: federal_register_of_legislation:F2016L01332
Segment Type: reg
Provision Reference: reg 194 (pt 2/2)
Character Range: 327711–330425

with insulin. TWENTY Diabetes mellitus uncontrolled.

   No age adjustment permitted for this table

A rating from this table is to be selected when the endocrine disorder is not associated with loss of function. If an assessable loss of function occurs in another system the higher rating is to be chosen. The two are not to be combined.

For the purposes of Table 12.1.1, "Diabetes mellitus uncontrolled" means blood sugar level consistently 15 mmol/L or more, despite treatment.

Other Impairment Table 12.1.2

      Impairment

ENDOCRINE DISORDERS (excluding Diabetes Mellitus)
      Ratings Criteria

               NIL              An endocrine disorder controlled by regular oral medication taken less often than daily or by injections less often than once a month.

                   * An endocrine disorder requiring daily oral medication.

                   * An endocrine disorder requiring regular injections not more often than once a month.

               FIVE             An endocrine disorder requiring injections not more often than once a fortnight.

      TEN An endocrine disorder requiring daily injections.

 No age adjustment permitted for this table

A rating from this table is to be selected when the endocrine disorder is not associated with loss of function. If an assessable loss of function occurs in another system the higher rating is to be chosen. The two are not to be combined.

    PART 12.2: THE HAEMOPOIETIC SYSTEM

    Conditions of the haemopoietic system include anaemias, leukaemias and polycythaemia.

    Haemopoietic conditions usually affect various other body systems, therefore loss of function for the condition is to be established by assessing the effect of the condition on those body systems. Some haemopoeitic conditions are also malignant conditions and may be assessed by applying Chapter 14 (Malignant Conditions). For very severe haemopoietic conditions, where many body systems are affected, Tables 16.1 and 16.2 in Chapter 16 (Activities of Daily Living) are also to be applied to rate the loss of function.

    Many anaemias will respond adequately to replacement or supplemental therapy. For example, the hypochromic anaemia of iron deficiency will usually respond to dietary iron supplementation and pernicious anaemia will usually respond to
    parenteral Vitamin B

Calculation of the impairment rating for loss of hameopoietic function

    Follow the steps below to calculate the impairment rating due to accepted loss of haemopoietic function:

    (Each step is elaborated on the following page.)

    STEP Establish which body systems are affected by the Page
     1 accepted haemopoietic condition. 197

    STEP